Czech and Slovak Ophthalmology 129 10.31348/2019/5/1 Review Long-term Observation of Patients with Sympathetic Ophthalmia from a Diagnostic and Therapeutic Perspective. Overview of Literature Krásný Jan https://orcid.org/0000-0002-0341-0094 Eckschlager Tomáš Smetana Karel Šach Josef https://orcid.org/0000-0001-9287-7915 Šubrtová Hana 6 4 2020 5 1

Aim: To evaluate options of diagnostic and therapeutic procedures of sympathetic ophthalmia (SO) compared with literature data. Backgroud: SO is an ocular autoimmune disease. It is characterized by disbalance in the imunoregulatory T-subsets within cell mediated immune response. Methods: File examination of SO by evaluation humoral and cellular immunity was ranked nukleolar test (NT). It evaulates the current status of lymphocyte activation based on the nucleolar morphology and RNA transcription aktivity. The classical histological examination was supported by immunohistochemical analysis of lymphocytic subpopulations in the eyeball enucleated for. SO in one case. Material: Five boys and men overall were monitored and treated in two studies from 1979 to 1994 and from 1999 to 2017 with SO In four cases it was subsequent after penetrating injuries and once after lensectomy with vitrectomy. The age of patients in the time of onset of SO was between 4 and 24 years (average 12 years). The time interval between insult and onset of SO varied between 10 days and 3 months (average 1.7 months). The relaps of disease appeared in the all cases in the time interval from 3 months to 38 years (average 15 years). Another two patients with SO were examined only in consultation: 16 years old boy with relaps of SO after cataract extraction and 71 years old women with SO subsequent after lensectomy and vitrectomy. There was examined and compared group of 19 patients with other types of uveitis in the same time. The lens-associated uveitis were caused after ocular contusion and penetrating eye injury in 16 patients (13 male patients). In another three cases (young women) with uveitidunderlined by II. or III. type of hypersenzitivity the enucleation of dolorous eyeball calmed down the secondary uveitis on their second eye without any change of immunosupressive treatment and without change in NT. Results: There were changes in the complex immunological laboratory tests results in the SO cases in the counts of activated lymphocytes in the peripheral blood. The count of activated lymphocytes was increased in SO cases unlike in lens-associated uveitis. There was detected in NT statistically significant difference (p = 0,0134) between the two groups of uveitis. The histological examination (5 eyes with SO and 7 eyes without sympathetic uveitis) confirmed the diagnoses, supporting basically the clinical diagnosis. The immunohistochemical examination corfirmed the presence of populations of T-lymphocytes, macrophages and also B-lymphocytes. A basis of immunosuppressive therapy was the combination of prednisone and azathioprin at the first time. Effective therapy featured cyklosporine later. Conclusion: The nucleolar test of lymphocytes draws attention of their up-to-day increased activity without the diferentiation of subpopulations and their absolute number increase related to the current activation of type IV. hypersensitivity (cell-mediated) in uveitis mechanism. The immunosupressive therapy calmes down this activation predominantly in SO, but also in other case sof uveitis with different types of hypersensivity. The immunohistochemical examination illustrates different presence oflymphocytic types according to the stage of SO.

 Sympathetic Ophthalmia Functional Lymphocytes Activity Immunosuppressive Therapy Lens-Associated Uveitis Transcription of RNA References Ahmad N., Salvi S., Rudle PA. et al.: Sympahtetic ophthalmia after ruthenium plaque brachytherapy. Br J Ophtalmol, 91; 2007: 399–401. Al-Halafi A., Dhibi HA., Hamade IH. et al.: The association of systematic disorders with Vogt-Koyanagi-Harada and sympathetic ophthalmia. Graefes Arch Clin Exp Ophthalmol, 249; 2011: 1229–1233. Arevalo JF., Garcia RA., Al-Dhibi HA. et al.: Update on sympathetic ophthalmia Middle East Afr J. Ophthalmol, 19; 2012: 13–21. Aujla JS., Lee GA., Vincent, SJ. et al.: Incidence of hy - potony and sympathetic ophthalmia following transscleral cyclophotocoagulation for glaucoma and a report of risk factors. Clin Experiment Ophthalmol, 41; 2013: 761–772. Auw-Haedrich C., Loeffler KU., Witschel H.: Sympathetic ophthalmia: an immunohistochemistry study of four cases. Ger J Ophthalmol, 5; 1996: 98–103. Aziz HA., Flynn HW., Young RC. et al.: Sympathetic ophthalmia: clinicopathologic correlation in a consecutive case series. Retina, 35, 2015: 1696–1703. Bartisch G.: ОFTALMOLOGIA (Augendienst). Stockel, Dre - ssden, 1583, p. 205. Brour J., Desjardins L., Lehoang P. et al.: Sympathetic ophthalmia after proton beam irradiation for choriodal melanoma. Ocul Immunol Inflamm, 20; 2012: 273–6. Brouzas D., Koutsandrea C., Moschos M. et al.: Massive choriodal hemorrhagae after intravitreal administration of bevacizumab (Avastin) for AMD followed by controlateral symphatetic ophthalmia. Clin Ophthalmol, 3; 2009: 457–9. Bruckner Z.: Ophtalmia sympathica in luetico po perforovaném plazivém vředu. Oftalmologický Sborník, 2; 1928: 393 – 424. Chan CC., Beneza D., Rodrigues MM. et al.: Immunohistochemistry and elektron microscopy of chorioidal infiltrates and Dalen-Fuchs nodules in sympathetic ophthalmia. Ophthalmology. 92; 1985: 580–590. Chan CC.: Relationships between sympathetic ophtalmia, phacoanaphylactic endophtalmitis and Vogt-Koyanagi-Harada disease. Ophthalmology, 95; l988: 619 –624. Chan CC., Roberge RG., Whitcup SP. et al.: 32 Case of sympathetic ophthalmia. A retrospective study at the National Eye Institute, Bethesda, Md., from 1982 to 1992. Arch Ophtalmol, 113; 1995: 597–600. Chan CC., Roberge FG.: Sympathetic Ophthalmia. In Pepose JS, Holland GJ, Wilhelmus KR.: Ocular Infection & Immunity, Mosby, New York, 1996, pp. 723–733. 15.Chang GC., Young LH.: Sympathetic ophtalmia. Semin Ophtalmol, 26; 2011: 316–320. Chen S., Aronow ME., Wang C. et al.: Classical pathology of sympathetic ophthalmia presented in a unique case. Open Ophthamol, 8; 2014: 32–38. Chu XK., Chan CC.: Sympathetic ophthalmia: to the twenty - -first century and beyond. J Ophthalmol Inflamm Infect, 3; 2013: 49–56. Cousin CW., Kraus-Mackiw E.: Lens-associated uveitis. In Pepose JS, Holland GJ, Wilhelmus KR: Ocular Infection & Immunity, Mosby, New York, 1996, pp. 507–528. Dienstbier E.: Konečná zpráva o výsledku léčby sympatické oftalmie penicilinem. Cs Oftal, 4; 1948: 408–411. Duke-Elder S (ed.): Text Book of Ophthalmology, Vol. IX. Disease of the uveal tract., Mosby, St.Louis, 1954, pp. 558–593. Eckschlager T., Kasal P., Smetana K.: Některé možnosti využití nukleolárního testu v klinické diagnostice. Prakt Lek, 60; l980: 667–68. Elschnig A.: Die antigena Wirkung des Augenpigmentes. Albrecht von Graefes Arch Ophthalmol, 76; 1910: 509. Friedlaender MH.: Alergy and Immunology of the Eye, Raven Press, NewYork, 1993, pp. 206–212. Fries PD., Char DH., Craford JB., et al.: Sympathetic ophthalmia complicating helium ion irradiation of a choriodal melanoma. Arch Ophthalmol, l05; l987: 1561–64. Fuchs E.: Über sympathisierende Entzündung zuerst bermerkungeen über seröse traumatische Iritis. Albrecht von Graefes Arch Ophthalmol, 61; 1905: 365. Fučíková T.: Imunologie. Vnitřní lékařství, Sv.V. Galén, Praha, 2002, 58 s. Furusato E, Shen DF, Cao X, et al.: Inflammatory Cytokine and Chemokine Expression in Sympathetic Ophthalmia. Histol Histpatol, 26; 2011:1145 51. Gass J.: Sympathetic ophthalmia after vitrectomy. Am J Ophthal, 93; l982: 552–58. Garcia-Arumi J., Montolio GM., Morral M. et al.: Sympathetic ophthalmia after surgical resection of iridociliary melanoma. Graefes Arch Clin Exp Ophthalmol, 244; 2006: 1353–1356. Hiyama T., Harada Y., Kiuchi Y.: Effective treatment of refractory sympathetic ophthalmia with glaucoma using adalimumab. Am J Ophthalmol Case Rep, 14; 2019: 1–4. Hrabánek J., Lukášová M., Smetana K.: Monitorování ak - tivních lymfocytů v periferní krvi pacientů po transplantaci kostní dřeně. Cas Lek Ces, 133; 1994: 80–2. Ibragimova NV., Tugolukova LV., Kravtsov V. et al.: The number of nucleoli in peripheral blood lymphocytes of the Chernobyl accident liquidator. Tsitologia, 43; 2001: 941 43. Inouye S., Ideta H., Ishikova H., et al.: Sympathetic ophthalmia following vitrectomy and /or retinal detachment surgery. Acta Soc Ophthalmol, 92; l988: 372–376. Jakobiec FA., Lefkowitch J., Knowles II. DM.: B- and T-lymphocytes in ocular diseases. Ophthalmology, 91; 1984: 635 654. John J., Iserle J.: Korepraxe fotokoagulací a sympatická oftalmie. Cesk Slov Oftalmol, 33; 1977: 377–82. Kaneko Y., Wu GS., Saraswathy S. et al.: Immunopathologic processes in sympathetic ophthalmia as signified by microR- NA profiling. Invest Ophthalmol Vis, Sci, 53; 2012: 4197–204. Kaplan H., Waldrep JC., Chan WC. et al.: Human sympathetic ophthalmia immunologic analysis of the vitreous et uvea. Arch Ophthalmol, 104; l986: 240–4. 38 Karel I., Krejčí L.: Naše dosavadní zkušenosti při léčbě sym - patické oftalmie. Cesk Slov Oftalmol, 14; 1958: 468–471. Kavka J.: K prevenci a léčbě soucitného onemocnění. Cesk Slov Oftalmol, 23; 1967: 212–4. Kim JB., Jeroudi A., Angels-Han ST. et al.: Adalimumab for pediatric sympathetic ophthalmia. JAMA Ophthalmol, 132; 2014: 1022–24. Kilmartin DJ., Dick AD., Forrester JV.: Prospective surveillan - ce of sympathetic ophthalmia in the UK and republic of Ireland. Brit J Ophthalmol, 84; 2000: 259–263. Klimartin DJ., Wilson D., Liversidge J. et al.: Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients. Br J Ophthalmol, 85; 2001: 281–286. Korčáková L., Reneltová J., Hašková V.: Možnost diagnostiky při transplantaci ledvin podle morfologie nukleolů cirkulujících lymfocytů, Cas Lek Ces, 114; 1975: 616–618. Korčáková L., Pekárek J., Rovenský J. et al.: Lymphocyte nucleolar activation as a marker of autoimmune disorders. Immunology 31; 1976: 803–805. Krásná J., Mezerová V., Krásný J.: Hodnocení efektivnos - ti léčby neinfekčních uveitid. Cesk Slov Oftalmol, 69; 2013: 110–116. Krásný J.: Závěrečná zpráva IGA 1152-3: Komplexní hodnocení péče o děti s imunopatologickým onemocněním oka, 1992–1994. Krásný J.: Uvea. In Kolín J, a kol.: Oftalmologie praktického lékaře. Karolinum, Praha, 1994, s. 9–111. Krásný J., Honzová S.: Vogt-Koyanagi-Harada syndrom u dětí. Cesk Slov Oftalmol, 51; 1995: 156–165. Kyoichi O., Shinji K., Keiji O. et al.: Surface markers of periferal blood lymphocytes in Vogt-Koyanagi-Harada diseases. J Clin Lab Immunol, 17, 1985: 49–52. Lam S., Tessler HH., Lam BL. et al.: High incidence of sympathetic ophthalmia after contakt and noncontact neodymiumYAG-cyclotherapy. Ophthalmology, 99; l992: 1818–2. Lubin JR., Albert DM., Weinstein M.: Sixty-five years of sym - pathetic ophthalmia. A clinicopathologic review of 105 cases 1913-1978. Ophthalmology, 87; l980:109–121. MacKenzie W.: A practical treatment on the diseases of the eye. 3rd ed. Longman, London, 1840: pp. 523–534. Muakkassa NW., Witkin AJ.: Spectral-domain optical coherence tomography of sympathetic ophthalmia with Dalen- Fuchs nodules. Ophthal Surg Lasers Imaging Retina. 45; 2014: 610–612. Müller-Hermelink HK., Kraus W.: Recent topic in the pathology of uveitis. In Kraus-Mackiw E, O´Connor GR: Uveitis, Pathophysiology and Therapy, Thieme-Stratton Inc., New York, l986, pp. 155–203. Nguyen AM., Rao NA.: Oxidative photoreceptor cell damage in autoimmune uveitis. J Ophthalmol Inflamm Infect, 1; 2011: 7–13. Nussenblatt RB., Palestine AG.: Uveitis, Fundamentals and Clinical Practice, YBMP, New York, l989, pp. 257 273. Oláh Z.: Príspevok k patologii sympatickej oftalmie. Cesk Slov Oftalmol, 23; 1967: 35–40. Parvaresh MM., Falavarjani KG.: Presumed sympathetic ophthalmia after scleral bucking surgery. Retin Cases Brief Rep, 4; 2013: 331–333. Patel SS., Dodds EM., Echandi LV. et al.: Long-term, drug- -free remission of sympathetic ophthalmia with high-dose, short-term chlorambucil therapy. Ophthalmology, 121; 2014: 596–602. Pusey B.: Cytotoxin and sympathetic ophthalmia. Arch Ophthalmol, 32; 1903: p. 334. Rao NA.: Mechanisms of imflammatory response in sym - pathetic ophthalmia and VKH syndrome. Eye, 11; 1997: 213–216. Reynard M., Shulman IA., Azen, SP. et al.: Histocompatibility antigens in sympathetic ophthalmia. Am J Ophthalmol, 95; l983: 216–221. Roberts F., Chee KT.: Lee´s Ophtalmic Histopathology, 3th ed., Springer-Verlang, London, 2014, 466 pp. Saatci AO., Ayhan Z., Ipek SC. et al.: Intravitreal Aflibercept as an adjunct to systemic therapy in a case chorioidel neovascular membrane associated with sympathetic ophthalmia. Turk J Ophthalmol, 48; 2018: 208–11. Shen J., Fang W., Jin XH. et al.: Sympathetic ophthalmia caused by a severe ocular chemical burn: a case report and literature review. Int J Clin Exp Med, 8; 2015: 2974–8. Sisk RA., Davis JL., Dubovy SROV., et al.: Symphatetic ophthalmia following vitrectomy for endophtalmitis after intravitreal bevacizumab. Ocul Immunol Inflamm, 16; 2008: 236–238. Smetana K.: Poznámky k vyšetřovaní nukleolů v lymfocytech. Imunol Zpravodaj, 7; l976: 399–419. Smetana K.: A futher contribution on the question of the incidence of nucleoli in the nuclei of mature lymphocytes in man. Folia Biol (Praha), 7; 1961: 268–274. Smetana K., Freireich, EJ., Busch H.: Chromatin structures in ring-shaped nucleoli of human lymphocytes. Exptl Cell Res, 52; 1968: 112-128. Smetana K., Gyorkey F., Gyorkey P. et al.: Comparative studies on the ultrastructure of nucleoli in human lymphosarcoma cells and leukemic lymphocytes. Cancer Research, 30; 1970: 1149–55. Smetana K., Lejnar J., Potměšil M.: A futher contribution to the demonstration of RNA and nucleoli of blood cells in smear preparations. Folia Haemat, 91; 1969: 4–9. Smetana K., Lejnar J., Sálková J.: Studies on nucleoli in rossetting T and B lymphocytes of the human peripheral blood. Folia Haematol Int Klin Morphol Blutforsch, 107; 1980: 720–7. Smetana K., Rosa L., Šubrtová H. et al.: Futher studies on satellite nucleoli of lymphocytes in patients suffering from B chronic lymphatic leukaemia. Int J Tissue React, 16; 1994: 181–185. Sváčová H., Izák M., Timová S. et al.: Sympatická oftalmia. Cesk Slov Oftalmol, 40, 1990: 218–222. Svozílková P., Říhová .E, Brichová M. et al.: Sympatická oftalmie. Cesk Slov Oftalmol, 62; 2006: 218–223. Svozílková P.: Sympatická oftalmie. In Říhová E, a kol.. Uveitidy, Praha, Grada, 2009, s. 59–60. Štepán J., Smetana K., Smolíková M. et al.: Lymphocyte nucleoli in the peripheral blood and knee joint effusions in patients with rheumatoid arthritis. Z Rheumatol, 37; 1978: 40–4. Tan XL., Seen S., Dutta-Majumder P. et al.: Anylysis of 130 cases of sympathetic ophthalmia – a retrospective multicenter case series. Ocul Imunol Inflamm, 12; 2018: 1–8. Toriyama K., Miyajima Y., Lijima F.: Two cases of sympathetic ophthalmia following in intraocular lens Implantation Folia Ophthalmol, 40; l989: 32–5. Tyagi M., Agarwal K., Reddy Pappuru RR. et al.: Sympathetic ophthalmia after vitreoretinal surgeries: incidence, clinical presentations and outcomes of rare disease. Semin Ophthalmol, 32; 2019: 157–62. Vejdovský V.: Sympathická ophtalmie po operaci šedého zákalu. Oftalmologický Sborník, 7; 1932: 109 – 111. Wocker L., Januschowski K.: Steroid implant in treatment of sympathetic ophthalmia: intravitreal implant of dexamethasone in cystoid macular edema in the context of sympathetic ophthalmia. Ophthalmologe, 116; 2019: 380–3. Zheng C., Wu AY.: Enucleation versus evisceration in ocular trauma: a retrospective review and study of current literature. Orbit, 32; 2013: 356–61.